Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Phase 4 IOP Signals Associated With ILUVIEN®

ClinicalTrials.gov ID: NCT02424019

Public ClinicalTrials.gov record NCT02424019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg

Study identification

NCT ID
NCT02424019
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Alimera Sciences
Industry
Enrollment
153 participants

Conditions and interventions

Interventions

  • ILUVIEN 0.19 MG Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 5, 2015
Primary completion
Jul 28, 2020
Completion
Jul 30, 2020
Last update posted
Jan 10, 2022

2015 – 2020

United States locations

U.S. sites
41
U.S. states
23
U.S. cities
39
Facility City State ZIP Site status
Retina Consultants of Arizona Phoenix Arizona 85014
Retina Centers, P.C. Tucson Arizona 85704
Retina and Macula Institute Glendale California 91203
Atlantis Eye Care Huntington Beach California 92647
Northern California Retina Vitreous Medical Group, Inc. Mountain View California
Orange County Retina Medical Group Santa Ana California 92705
Eye Care Center of Northern Colorado Longmont Colorado 80503
Retina Vitreous Associates of Florida St. Petersburg Florida
Southeast Retina Center, P.C. Augusta Georgia 30909
Retina Consultants of Hawaii ‘Aiea Hawaii 96701
Chicagoland Eye and Retina Foundation Chicago Illinois 60601
The University of Illinois at Chicago Chicago Illinois 60612
University Retina and Macula Associates Oak Forest Illinois 63017
Illinois Retina Associates, SC Oak Park Illinois 60304
Carle Foundation Hospital Urbana Illinois 61801
Wolfe Eye Clinic West Des Moines Iowa 50266
Sabates Eye Center Research Division Leawood Kansas 66211
Paducah Retinal Center Paducah Kentucky 42001
Eye Associates of Northeast Louisiana West Monroe Louisiana 71291
University of Maryland Eye Associates Baltimore Maryland 21201
Johns Hopkins Hospital Baltimore Maryland 21287
Wayne State University Detroit Michigan 48201
Lifelong Vision Foundation Chesterfield Missouri 63017
Discover Vision Centers Independence Missouri 64055
Eyesight Ophthalmic Services, PA Portsmouth New Hampshire 03801
New Jersey Retina New Brunswick New Jersey 08901
Retina Associates of New Jersey Teaneck New Jersey 07666
Joseph R. Podhorzer, MD PLLC Brooklyn New York 11223
Ophthalmic Consultants of Long Island Lynbrook New York 11563
Macula Care New York New York 10021
Island Retina Shirley New York
Tulsa Retina Consultants Tulsa Oklahoma 74133
Laurel Eye Clinic Brookville Pennsylvania
Pennsylvania Retina Specialist, PC Camp Hill Pennsylvania 17011
Southeastern Retina Associates, PC Kingsport Tennessee 37660
Retina Research Center Austin Texas 78705
Valley Retina Institute, PA McAllen Texas 78503
Medical Center Ophthalmology Associates San Antonio Texas
Hampton Roads Retina Center Chesapeake Virginia 23320
Virginia Retina Center Warrenton Virginia 20186
Cascade Eye and Skin University Place Washington 98467

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02424019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02424019 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →